MILLAR R A, KEENER E B, BENFEY B G
Br J Pharmacol Chemother. 1959 Mar;14(1):9-13. doi: 10.1111/j.1476-5381.1959.tb00921.x.
The intravenous administration of the antiadrenaline drug phenoxybenzamine (Dibenzyline) markedly raised the arterial adrenaline and noradrenaline concentration in dogs lightly anaesthetized with thiopentone. Graded haemorrhage led to a further rise in the amounts of amine. In adrenalectomized dogs, phenoxybenzamine moderately increased the plasma noradrenaline concentration. During haemorrhagic hypotension, previous treatment of adrenalectomized animals with phenoxybenzamine led to a significantly greater rise in plasma noradrenaline compared with that of adrenalectomized animals subjected to haemorrhage without treatment with phenoxybenzamine. Thus, phenoxybenzamine (1) raised plasma amine concentration largely due to adrenal medullary stimulation, and (2) led to increased plasma noradrenaline concentrations during sympathetic stimulation in adrenalectomized animals. The previous administration of phenoxybenzamine reduced the amount of blood which could be withdrawn before final circulatory collapse in both normal and adrenalectomized dogs.
用硫喷妥钠轻度麻醉的犬静脉注射抗肾上腺素药物酚苄明(双苄胺)后,动脉血中肾上腺素和去甲肾上腺素浓度显著升高。分级出血导致胺类物质含量进一步增加。在肾上腺切除的犬中,酚苄明适度增加血浆去甲肾上腺素浓度。在出血性低血压期间,与未用酚苄明治疗而出血的肾上腺切除动物相比,先前用酚苄明治疗的肾上腺切除动物血浆去甲肾上腺素的升高幅度明显更大。因此,酚苄明(1)主要通过刺激肾上腺髓质提高血浆胺类浓度,(2)导致肾上腺切除动物在交感神经刺激期间血浆去甲肾上腺素浓度升高。预先给予酚苄明可减少正常犬和肾上腺切除犬在最终循环衰竭前可抽取的血量。